PGT-A
Right Embryo
Unique innovation to improve the odds of pregnancy and IVF success
PGT-A
Right Embryo
Unique innovation to improve the odds of pregnancy and IVF success
What is PGT-A testing?
Preimplantation Genetic Testing for Aneuploidies (PGT-A)
PGT-A is a genetic test performed on cells taken from embryos produced through IVF. PGT-A can give information about the genetic health of your embryo to help your care team select an embryo for transfer, helping to improve your chances of achieving a successful pregnancy.
Chromosomes are structures made of protein and DNA that carry genetic information from the sperm and egg to the embryo. A chromosomally normal, or euploid, embryo contains 23 pairs of chromosomes amounting to 46 in total. One pair of chromosomes comes from the egg and the other the sperm. When an embryo doesn’t have the correct number of chromosomes it is called aneuploid. A euploid embryo is much more likely to result in successful implantation and the birth of a baby.
How the PGT-A process works
Is PGT-A testing for me?
PGT-A can benefit many IVF patients
Is PGT-A testing for me?
PGT-A can benefit many IVF patients
Research has shown PGT-A can:
” We wanted to have the best chance to avoid transferring embryos that could lead to miscarriage or severe birth defects. Each failed transfer would have had a significant financial impact. “
Caitie (A CooperSurgical PGT-A patient)
To read Caitie’s story click here
What does the PGT-A data tell us?
The number of euploid embryos decreases with age
All patients are at risk of producing aneuploid embryos. As women age, the potential for aneuploid embryos increases. PGT-A can help all families increase their chances of a successful pregnancy.
A retrospective study that investigated 2,464 IVF cycles showed PGT-A significantly improves the live birth rate for patients of all ages.³
Live births are increased across all age groups with PGT-A versus non-PGT-A users.
Live births are increased across all age groups with PGT-A versus non-PGT-A users
Percentage of live births per embryo transferred with and without PGT-A. Data reached statistical significance.
How is our PGT-A test different?
CooperSurgical® uses artificial intelligence (PGTai® Platform) to analyze your embryo data
How our test works
Our artificial intelligence platform is based on thousands of embryos that resulted in healthy live births. This means the chromosomal status of your embryo is checked against the data taken from these embryos, improving the accuracy of our test.
How PGTai® Platform benefits you compared to other PGT-A technology
Improving patient outcomes
PGTai® Platform significantly increases ongoing pregnancy and live birth rates
A study investigated outcomes from almost 25,000 IVF embryos using our PGTai technology compared to standard technology (without AI).2
” We chose to have PGT-A testing with CooperSurgical to find out more about our embryos and to be able to make a better decision with all the information possible “
Rumman (A CooperSurgical PGT-A patient)
To read Rumman’s story click here
Documents
Reproductive Genetic Testing Brochure – English
Reproductive Genetic Testing Brochure – Czech
Reproductive Genetic Testing Brochure – French
Reproductive Genetic Testing Brochure – German
Reproductive Genetic Testing Brochure – Greek
Reproductive Genetic Testing Brochure – Italian
Reproductive Genetic Testing Brochure – Spanish(LATAM)
Reproductive Genetic Testing Brochure – Spanish
Reproductive Genetic Testing Brochure – Turkish
